Justin Zelin
Stock Analyst at BTIG
(3.78)
# 791
Out of 4,412 analysts
30
Total ratings
33.33%
Success rate
16.05%
Average return
Main Sectors:
Top Industries:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CARM Carisma Therapeutics | Initiates: Buy | $6 | $1.67 | +259.28% | 1 | Apr 11, 2024 | |
| VKTX Viking Therapeutics | Maintains: Buy | $100 → $125 | $75.42 | +65.74% | 4 | Mar 26, 2024 | |
| IDYA IDEAYA Biosciences | Initiates: Buy | $55 | $40.65 | +35.30% | 1 | Mar 8, 2024 | |
| VSTM Verastem | Assumes: Buy | $27 | $9.63 | +180.37% | 1 | Nov 21, 2023 | |
| LYRA Lyra Therapeutics | Assumes: Buy | $15 | $4.73 | +217.12% | 1 | Oct 6, 2023 | |
| MBIO Mustang Bio | Maintains: Buy | $20 → $16 | $0.24 | +6,651.05% | 4 | Aug 15, 2023 | |
| IMCR Immunocore Holdings | Maintains: Buy | $85 → $91 | $58.10 | +56.63% | 2 | Aug 11, 2023 | |
| ACET Adicet Bio | Maintains: Buy | $20 → $10 | $1.59 | +528.93% | 2 | Aug 10, 2023 | |
| PROK ProKidney | Initiates: Buy | $16 | $2.30 | +595.65% | 1 | Jul 25, 2023 | |
| ETNB 89bio | Maintains: Buy | $30 → $37 | $8.53 | +333.76% | 2 | Jul 3, 2023 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $34 → $35 | $21.28 | +64.47% | 1 | Jun 26, 2023 | |
| LEGN Legend Biotech | Maintains: Buy | $85 → $90 | $45.14 | +99.38% | 2 | Jun 13, 2023 | |
| KURA Kura Oncology | Initiates: Buy | $31 | $20.06 | +54.54% | 1 | May 17, 2023 | |
| NVO Novo Nordisk | Maintains: Buy | $10 → $16 | $126.88 | -87.78% | 1 | Mar 28, 2023 | |
| MEIP MEI Pharma | Downgrades: Neutral | n/a | $3.08 | - | 2 | Dec 6, 2022 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $21 → $10 | $2.34 | +327.35% | 3 | Nov 16, 2022 | |
| PSTX Poseida Therapeutics | Initiates: Buy | n/a | $2.32 | - | 1 | May 18, 2021 |
Carisma Therapeutics
Apr 11, 2024
Initiates: Buy
Price Target: $6
Current: $1.67
Upside: +259.28%
Viking Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $75.42
Upside: +65.74%
IDEAYA Biosciences
Mar 8, 2024
Initiates: Buy
Price Target: $55
Current: $40.65
Upside: +35.30%
Verastem
Nov 21, 2023
Assumes: Buy
Price Target: $27
Current: $9.63
Upside: +180.37%
Lyra Therapeutics
Oct 6, 2023
Assumes: Buy
Price Target: $15
Current: $4.73
Upside: +217.12%
Mustang Bio
Aug 15, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $0.24
Upside: +6,651.05%
Immunocore Holdings
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $58.10
Upside: +56.63%
Adicet Bio
Aug 10, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $1.59
Upside: +528.93%
ProKidney
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $2.30
Upside: +595.65%
89bio
Jul 3, 2023
Maintains: Buy
Price Target: $30 → $37
Current: $8.53
Upside: +333.76%
Syndax Pharmaceuticals
Jun 26, 2023
Maintains: Buy
Price Target: $34 → $35
Current: $21.28
Upside: +64.47%
Legend Biotech
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $45.14
Upside: +99.38%
Kura Oncology
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $20.06
Upside: +54.54%
Novo Nordisk
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $126.88
Upside: -87.78%
MEI Pharma
Dec 6, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.08
Upside: -
CASI Pharmaceuticals
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $2.34
Upside: +327.35%
Poseida Therapeutics
May 18, 2021
Initiates: Buy
Price Target: n/a
Current: $2.32
Upside: -